Alex Newman

Alex Newman, a writer specializing in behavioral psychology and finance, joins Julian Hofmann to discuss intriguing investment insights. They dive into Ashtead's move to list in the US and its market implications. Newman elaborates on how biases affect investment decisions, advocating for awareness in behaviors. Hofmann reviews Victrex's surprising share rise amid investor optimism. They also touch on the dynamics surrounding the acquisition of fintech firm Equals, exploring its market potential and the complex landscape of investor reactions.

Join Alex Newman, author and market analyst, alongside Jemma Slingo, who dives into the latest financial figures from Ashtead and Redde Northgate. They discuss Ashtead's challenges amid rising interest rates and the complexities of Redde Northgate's post-merger legacy issues. Newman brings to light why this might be a golden era for stockpickers, exploring the shortcomings of active funds and their potential resurgence. Together, they shed light on the shifting landscape of investment strategies and what it means for future market performance.